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Src family kinases are best known for their role in 
malignant transformation and tumor progression, 
as well as signaling through cell surface integrins 
(Parsons and Parsons, 2004; Playford and Schaller, 
2004). Due to their role in cancer development 
and progression, Src family kinases have become 
major targets of cancer therapy (Kim et al., 2009; 
Zhang and Yu, 2012). Src family kinases are also 
present in immune cells with dominant expres-
sion of Lck and Fyn in T cells and NK cells; Lyn, 
Fyn, and Blk in B cells and mast cells; and Hck, 
Fgr, and Lyn in myeloid cells such as neutrophils 
and macrophages (Lowell, 2004).
The best known function of Src family kinases 
in the immune system is their role in integrin 
signal transduction. Indeed, Hck, Fgr, and Lyn 
mediate outside-in signaling by 1 and 2 inte-
grins in neutrophils and macrophages (Lowell 
et al., 1996; Meng and Lowell, 1998; Mócsai 
et al., 1999; Suen et al., 1999; Pereira et al., 2001; 
Giagulli et al., 2006; Hirahashi et al., 2006), Lck 
participates in LFA-1–mediated T cell responses 
(Morgan et al., 2001; Fagerholm et al., 2002; 
Feigelson et al., 2001; Suzuki et al., 2007), and Src 
family kinases are required for LFA-1–mediated 
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Although Src family kinases participate in leukocyte function in vitro, such as integrin signal 
transduction, their role in inflammation in vivo is poorly understood. We show that Src family 
kinases play a critical role in myeloid cell–mediated in vivo inflammatory reactions. Mice lacking 
the Src family kinases Hck, Fgr, and Lyn in the hematopoietic compartment were completely 
protected from autoantibody-induced arthritis and skin blistering disease, as well as from the 
reverse passive Arthus reaction, with functional overlap between the three kinases. Though the 
overall phenotype resembled the leukocyte recruitment defect observed in 2 integrin–deficient 
(CD8/) mice, Hck/Fgr/Lyn/ neutrophils and monocytes/macrophages had no cell-
autonomous in vivo or in vitro migration defect. Instead, Src family kinases were required for the 
generation of the inflammatory environment in vivo and for the release of proinflammatory 
mediators from neutrophils and macrophages in vitro, likely due to their role in Fc receptor 
signal transduction. Our results suggest that infiltrating myeloid cells release proinflammatory 
chemokine, cytokine, and lipid mediators that attract further neutrophils and monocytes from 
the circulation in a CD8-dependent manner. Src family kinases are required for the generation 
of the inflammatory environment but not for the intrinsic migratory ability of myeloid cells.
© 2014 Kovács et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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phagocytosis of IgG-coated red blood cells is delayed but not 
blocked in Hck/Fgr/Lyn/ macrophages (Fitzer-Attas 
et al., 2000; Lowell, 2004). The differential requirement for 
Src family kinases in TCR, BCR, and Fc receptor signaling 
is thought to derive from the fact that Syk, but not ZAP-70, 
is itself able to phosphorylate ITAM tyrosines (Rolli et al., 
2002), making Src family kinases indispensable for signaling 
by the ZAP-70–coupled TCR but not by the Syk-coupled 
BCR and Fc receptors.
Autoantibody production and immune complex for-
mation is one of the major mechanisms of autoimmunity- 
induced tissue damage. In vivo models of those processes 
include the K/B×N serum transfer arthritis (Korganow et al., 
1999) and autoantibody-induced blistering skin diseases (Liu 
et al., 1993; Sitaru et al., 2002, 2005), which mimic important 
aspects of human rheumatoid arthritis, bullous pemphigoid, 
and epidermolysis bullosa acquisita. Activation of neutrophils 
or macrophages (Liu et al., 2000; Wipke and Allen, 2001; 
Sitaru et al., 2002, 2005; Solomon et al., 2005), recognition of 
immune complexes by Fc receptors (Ji et al., 2002; Sitaru 
et al., 2002, 2005), and 2 integrin–mediated leukocyte recruit-
ment (Watts et al., 2005; Liu et al., 2006; Chiriac et al., 2007; 
Monach et al., 2010; Németh et al., 2010) are indispensable 
for the development of those in vivo animal models.
signal transduction and target cell killing by NK cells (Riteau 
et al., 2003; Perez et al., 2004).
Src family kinases also mediate TCR signal transduction 
by phosphorylating the TCR-associated immunoreceptor 
tyrosine-based activation motifs (ITAMs), leading to recruitment 
and activation of ZAP-70 (van Oers et al., 1996; Zamoyska 
et al., 2003; Palacios and Weiss, 2004). However, their role in 
receptor-proximal signaling by the BCR and Fc receptors is 
rather controversial. Although the combined deficiency of 
Lyn, Fyn, and Blk results in defective BCR-induced NF-B 
activation, receptor-proximal BCR signaling (ITAM phos-
phorylation) is not affected (Saijo et al., 2003). Genetic defi-
ciency of Lyn, the predominant Src family kinase in B cells, 
even leads to enhanced BCR signaling and B cell–mediated 
autoimmunity (Hibbs et al., 1995; Nishizumi et al., 1995; 
Chan et al., 1997). Similarly, both positive (Hibbs et al., 1995; 
Nishizumi and Yamamoto, 1997; Parravicini et al., 2002; 
Gomez et al., 2005; Falanga et al., 2012) and negative 
(Kawakami et al., 2000; Hernandez-Hansen et al., 2004; 
Odom et al., 2004; Gomez et al., 2005; Falanga et al., 2012) 
functions for Fyn and Lyn during Fc receptor signaling in 
mast cells have been reported. In addition, Hck/Fgr/ 
neutrophils respond normally to IgG immune complex–induced 
activation (Lowell et al., 1996) and Fc receptor–mediated 
Figure . Myeloid Src family kinases are indispensable for autoantibody-induced arthritis. Intact (A–D) WT or Hck/Fgr/Lyn/ (3× SFK KO) 
mice or bone marrow chimeras (E–H) generated by transplanting WT or Hck/Fgr/Lyn/ bone marrow to WT (WT►WT and 3× SFK KO►WT, respec-
tively) or Hck/Fgr/Lyn/ recipients (WT►3× SFK KO) were injected with B×N (control) or K/B×N (arthritic) serum i.p. on day 0. Arthritis development 
was followed by photographing on day 8 (A and E), clinical scoring of the hind limbs (B and F), ankle thickness measurement (C and G) and an articular 
function test (hanging on a wire grid; D and H). Images are representative of, and quantitative data show mean and SEM from, 4 control and 6 arthritic 
serum-treated individual mice per group from 2 independent experiments (A–D) or 4–12 control and 7–26 arthritic serum-treated mice per group from 
2–8 independent experiments (E–H). D and H show results from functional test performed 6–21 times on each mouse between days 6–12.
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RESULTS
Hck, Fgr, and/or Lyn are required  
for autoantibody-induced arthritis
To determine the role of Src family kinases in autoantibody-
induced arthritis, we first tested the development of K/B×N 
serum transfer arthritis in Hck/Fgr/Lyn/ triple knock-
out mice. As shown in Fig. 1 A, administration of arthritogenic 
(K/B×N) serum triggered robust arthritis in WT but not 
Hck/Fgr/Lyn/ animals. The Hck/Fgr/Lyn/ 
mutation completely protected mice from disease develop-
ment both in terms of visible clinical signs (Fig. 1 B; P = 4.2 × 
105; n = 6) and ankle thickening (Fig. 1 C; P = 4.5 × 104; 
The role of Src family kinases in 2 integrin signaling and 
the requirement for 2 integrins during autoantibody- 
induced in vivo inflammation prompted us to test the role of 
Src family kinases in autoantibody-induced inflammatory 
disease models. We found that Hck/Fgr/Lyn/ mice 
were completely protected from autoantibody-induced ar-
thritis and inflammatory blistering skin disease. Surprisingly, 
this was not due to a cell-autonomous defect in 2 integrin–
mediated leukocyte migration but to defective generation of 
an inflammatory microenvironment, likely due to the role of 
Src family kinases in immune complex–induced neutrophil 
and macrophage activation.
Figure 2. Overlapping role of Hck, Fgr, and Lyn 
during autoantibody-induced arthritis. (A) Arthritis 
was induced and assessed in WT, Hck/, Fgr/, and 
Lyn/ single, Hck/Fgr/, Hck/Lyn/, and Fgr/ 
Lyn/ double, and Hck/Fgr/Lyn/ (3× SFK KO) 
triple knockout bone marrow chimeric mice as de-
scribed in the Fig. 1 legend. Controls for all genotypes 
were combined in B–D. E–G show cumulative data 
obtained from the experiments shown in B–D. Images 
are representative of, and quantitative data show mean 
and SEM from 1–12 control and 7–26 arthritic serum-
treated mice per genotype from 10 independent ex-
periments. The joint functional test (D and G) were 
performed 3–24 times on each mouse between days  
6 and 12. The WT and Hck/Fgr/Lyn/ chimeric data 
include results presented in Fig. 1 (E–H). AUC, area 
under the curve.
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both control and arthritic serum-treated mice in Fig. 2 (E–G). 
Hck, Fgr, or Lyn single deficiency did not affect arthritis 
development in our model (p-values for clinical score, ankle 
thickness, and joint functional test were between 0.34 and 
0.98; n = 10–11). Hck/Fgr/ and Fgr/Lyn/ double 
knockout chimeras showed no protection either (0.086 ≤ P ≤ 
0.99; n = 4–10). The Hck/Lyn/ double mutation caused 
substantial but incomplete reduction of arthritis development 
(P = 1.2 × 1010, 1.4 × 109, and 0.031 for clinical score, 
ankle thickness, and joint functional test, respectively; n = 5–7); 
however, the poor overall health status of these chimeras (Xiao 
et al., 2008) may have affected their response in our model. 
Importantly, complete protection from arthritis development 
was only seen in the absence of all three kinases (P = 2.0 × 
1012, 3.5 × 1011, and 1.2 × 107, respectively; n = 14–21), 
indicating significant functional overlap between Hck, Fgr, 
and Lyn during autoantibody-induced inflammation.
Other immune complex–induced inflammation models
We also tested the effect of the Hck/Fgr/Lyn/ mutation 
on other autoantibody-induced inflammatory processes. Sys-
temic administration of collagen VII–specific antibodies (a mouse 
model of the human blistering skin disease epidermolysis bullosa 
acquisita; Sitaru et al., 2005, 2007) triggered skin inflammation 
in WT but not Hck/Fgr/Lyn/ mutant animals (Fig. 3 A). 
Hck/Fgr/Lyn/ mutants were completely protected both 
in terms of the body surface area affected (Fig. 3 B; P = 1.5 × 
1010; n = 11) and the overall disease severity (Fig. 3 C; P = 
1.1 × 1010; n = 13). However, circulating collagen VII–specific 
antibody titers were not affected by the Hck/Fgr/Lyn/ 
n = 6). We also tested the ability of the mice to hold onto 
the lower side of a wire grid as a measure of joint function 
( Jakus et al., 2009). Although the majority of arthritic serum-
treated WT mice fell off the grid within a few seconds, most 
of the Hck/Fgr/Lyn/ were able to hold onto the grid 
throughout the entire 20-second assay period (Fig. 1 D; 
P = 9.5 × 106; n = 6).
We also performed arthritis experiments in bone marrow 
chimeras generated by transplanting Hck/Fgr/Lyn/ bone 
marrow cells to WT recipients or vice versa. As shown in Fig. 1 
(E–H), bone marrow chimeras carrying Hck/Fgr/Lyn/ 
bone marrow cells in a WT recipient were completely pro-
tected from all signs of K/B×N serum transfer arthritis (P = 2.0 × 
1012, 3.5 × 1011, and 1.2 × 107 for clinical score, ankle 
thickness, and joint functional assay, respectively; n = 14–21), 
whereas Hck/Fgr/Lyn/ mice transplanted with WT 
bone marrow cells showed a normal disease course and an 
even somewhat more severe functional defect (P = 0.36, 0.59, 
and 0.028, respectively; n = 7). The above results indicate that 
expression of Hck, Fgr, and/or Lyn in the hematopoietic com-
partment is indispensable for the development of autoantibody-
induced arthritis in experimental mice.
Overlapping role of Hck, Fgr, and Lyn  
during autoantibody-induced arthritis
We next tested K/B×N serum transfer arthritis in bone marrow 
chimeras with single or double deficiency of Hck, Fgr, or Lyn 
in the hematopoietic compartment. Representative hind limb 
images are shown in Fig. 2 A, quantitative analyses of arthritic 
serum-treated mice in Fig. 2 (B–D), and cumulated data for 
Figure . Src family kinases in autoanti-
body-induced skin blistering disease and the 
reverse passive Arthus reaction. (A–D) Blis-
tering skin disease was triggered in WT or  
Hck/Fgr/Lyn/ (3× SFK KO) mice or bone 
marrow chimeras by systemic injection of col-
lagen VII–specific (-CVII) antibodies. Skin dis-
ease was followed by photographing on day 14 
(A) and clinical assessment of the total body 
surface affected (B) and the overall disease se-
verity (C). The serum titer of -CVII antibodies 
was tested on day 6 by ELISA (D). Representative 
images (A) or mean and SEM (B–D) from 5–7 
control (1 intact and 4–6 bone marrow chimeric) 
and 13–14 -CVII–treated (4 intact and 9–10 
bone marrow chimeric) mice per genotype from 
4 independent experiments are shown. No dif-
ference between intact and chimeric mice of  
the same hematopoietic genotype was ob-
served (not depicted). (E and F) Reverse passive 
Arthus reaction was triggered in intact WT or 
Hck/Fgr/Lyn/ (3× SFK KO) mice by sys-
temic administration of ovalbumin, followed by 
intradermal injection of normal (control) or anti-
ovalbumin (anti-Ova) rabbit serum into the left 
and right ears, respectively. Edema formation was assessed by determining the accumulation of radioactively labeled albumin from the circulation by NanoSPECT 
with a reference CT scan. Representative images (E) and mean and SEM (F) from 4–8 mice per genotype from 3 independent experiments are shown.
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animals (P = 0.013; n = 8). Collectively, Hck, Fgr, and Lyn are 
required for antibody-induced tissue damage in various in vivo 
inflammation models.
Myeloid cells fail to accumulate at the site of inflammation
We and others reported complete protection of CD18/ mice 
from K/B×N serum transfer arthritis, likely due to a cell- 
autonomous role for LFA-1 in migration of myeloid cells to the 
site of inflammation (Watts et al., 2005; Németh et al., 2010; 
Monach et al., 2010). Given the role for Src family kinases in 
integrin signaling in myeloid cells and in autoantibody-induced 
mutation (Fig. 3 D; P = 0.34; n = 2). Importantly, intact 
Hck/Fgr/Lyn/ mice and Hck/Fgr/Lyn/ bone 
marrow chimeras were both completely protected from skin 
disease in our model (unpublished data).
We also tested the reverse passive Arthus reaction triggered 
by systemic administration of ovalbumin followed by intra-
dermal injection of anti-ovalbumin into the ear. Edema forma-
tion was followed by imaging the accumulation of radioactively 
labeled albumin from the circulation. As shown in Fig. 3 
(E and F), anti-ovalbumin injection caused robust increase of 
vascular permeability in WT but not Hck/Fgr/Lyn/  
Figure . Myeloid cells fail to accumulate at the site of inflammation. Intact WT, CD18/ (CD18 KO), or Hck/Fgr/Lyn/ (3× SFK KO) mice 
were subjected to K/B×N serum transfer arthritis (A, B, D, and E) or autoantibody-induced skin blistering disease (C) as described in the legends to Figs. 1 
and 3. (A) Hematoxylin-eosin–stained sections of ankle joints 7 d after the serum transfer. Images are representative of 4 control and 6 arthritic serum-
treated mice per genotype from 2 independent experiments. Lower images were magnified from the upper sections. Bars, 200 µm. (B–D) The ankle area or 
the front paw was flushed (B, D, and E) or the nasal skin was digested (C), and the number of neutrophils (PMN; B and C) or monocytes/macrophages 
(mono/M; D and E) was determined by flow cytometry. Graphs represent mean and SEM of data obtained from 3–7 control and 5–13 arthritic serum-
treated mice per genotype from 2–5 independent experiments (B and D), 3–4 control and 6 arthritic serum-treated mice per genotype from 2 indepen-
dent experiments (E), or 2 control and 4 anti-CVII–treated mice per genotype from 2 independent experiments (C). a., ankle; f., front paw.
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animal (WT:WT, WT:CD18/, and WT:Hck/Fgr/Lyn/ 
chimeras, respectively). We then compared the percentage 
of CD45.2-positive cells in the blood and synovial tissue 
within the same individual mouse during K/B×N serum trans-
fer arthritis.
In chimeras having CD45.2-expressing WT and CD45.1-
expressing WT hematopoietic tissues (WT:WT chimeras), the 
percentage of CD45.2-positive neutrophils was similar in the 
blood and synovial infiltrate in all chimeras tested (Fig. 5 A). In 
contrast, in WT:CD18/ chimeras (Fig. 5 B), the percentage 
of CD45.2-expressing (i.e., CD18/) neutrophils in the in-
flamed synovium was much lower than that in the circulation, 
indicating a cell-autonomous recruitment defect of CD18/ 
neutrophils. Surprisingly, in WT:Hck/Fgr/Lyn/ chi-
meras (Fig. 5 C), no difference between the percentage of 
CD45.2-positive (i.e., Hck/Fgr/Lyn/) neutrophils in 
the blood and the synovial infiltrate could be observed, indi-
cating that Hck/Fgr/Lyn/ neutrophils can accumulate 
normally at the site of inflammation when WT cells are also 
present in the same animal. The results of such experiments 
performed on a large cohort of mice are summarized in Fig. 5 D, 
where each dot represents an individual mouse. Although dots 
of WT:WT and WT:Hck/Fgr/Lyn/ chimeras line up 
along the dotted line representing equal ratios in the blood and 
the synovium, dots of WT:CD18/ chimeras are shifted to 
the lower right, indicating reduced ability of CD18/ cells to 
enter the synovium from the circulation. The same data have 
also been used to calculate the relative migratory capacity of 
neutrophils of the different genotypes (Fig. 5 F). Those calcu-
lations confirmed a strong cell-autonomous recruitment defect 
of CD18/ neutrophils (P = 2.0 × 1012 and 1.0 × 109 for 
ankle and front paw, respectively; n = 10–14), whereas the 
accumulation of Hck/Fgr/Lyn/ neutrophils was even 
slightly higher (P = 0.021 and 0.11, respectively; n = 7–15) than 
that of WT cells within the same animal.
We have also tested the accumulation of monocytes/macro-
phages in a similar manner. As shown in Fig. 5 (E and G), al-
though CD18 deficiency caused a significant cell-autonomous 
reduction of the percentage of Ly6GF4/80+ macrophages 
in the synovial tissue (relative to the percentage of CD18/ 
cells among circulating Ly6GF4/80+ monocytes; P = 8.0 × 
106; n = 7), the Hck/Fgr/Lyn/ mutation did not af-
fect the accumulation of F4/80-positive cells in the inflamed 
synovium (P = 0.83; n = 5). The Hck/Fgr/Lyn/ muta-
tion had no effect on macrophage accumulation when the cells 
were identified as Ly6GCD11b+ cells either (Fig. 5, E and G; 
P = 0.37; n = 6). Collectively, when WT cells are present in 
mixed bone marrow chimeras, Hck/Fgr/Lyn/ neutro-
phils and monocytes/macrophages accumulate normally at 
the site of inflammation, arguing against a cell-autonomous 
migration defect of Hck/Fgr/Lyn/ myeloid cells.
Normal in vitro migration of Hck/Fgr/Lyn/ 
neutrophils and monocytes
We next tested the migration of neutrophils and mono-
cytes in an in vitro Transwell assay. As shown in Fig. 5 H, 
in vivo inflammation (Figs. 1–3), we next tested their role in 
leukocyte accumulation at the inflammatory site. As shown 
in Fig. 4 A, K/B×N serum transfer arthritis triggered robust 
leukocytic infiltration of the synovial area of WT but not 
Hck/Fgr/Lyn/ mice. Flow cytometric analysis revealed 
a dramatic increase of neutrophil numbers in the synovial tissue 
of arthritic serum-treated WT mice that was entirely depen-
dent on CD18 (Fig. 4 B; P = 6.8 × 105 and 1.6 × 104 for 
ankle and front limb, respectively; n = 5). Importantly, the 
Hck/Fgr/Lyn/ mutation also abrogated neutrophil in-
filtration at the synovial area (Fig. 4 B; P = 7.2 × 105 and 1.7 × 
104, respectively; n = 13). The defective neutrophil infiltration 
was not due to reduced circulating numbers of neutrophils 
because blood neutrophil counts were even higher in both 
CD18/ (10.7 ± 2.1 and 16.9 ± 5.7 thousand cells/µl before 
and on day 4 after K/B×N serum transfer, respectively; n = 4) 
and Hck/Fgr/Lyn/ (2.5 ± 0.6 and 4.6 ± 1.6 thousand 
cells/µl, respectively; n = 4) than in WT animals (0.6 ± 0.1 and 
1.4 ± 0.3 thousand cells/µl, respectively; n = 4).
We also tested neutrophil infiltration in the nasal skin dur-
ing autoantibody-induced skin blistering disease. As shown 
in Fig. 4 C, neutrophils infiltrated the skin of WT but not 
Hck/Fgr/Lyn/ animals (P = 0.0088; n = 4).
We next tested the accumulation of monocytes/macro-
phages. Ly6GF4/80+ cells infiltrated the synovial area of 
arthritic serum-treated WT mice, and this was again entirely 
dependent on the presence of CD18 (Fig. 4 D; P = 1.1 × 104 
and 1.6 × 104 for ankle and front paw, respectively; n = 5). 
The Hck/Fgr/Lyn/ mutation also completely abro-
gated the accumulation of Ly6GF4/80+ cells (Fig. 4 D; P = 1.1 
× 104 and 1.7 × 104, respectively; n = 13). Again, the defec-
tive infiltration was not due to reduced number of circulating 
monocytes because Ly6GF4/80+ blood monocyte counts in 
CD18/ (710 ± 144 and 1,591 ± 351 cells/µl on days 0 and 4, 
respectively; n = 4) and Hck/Fgr/Lyn/ mice (553 ± 
154 and 244 ± 59 cells/µl, respectively; n = 4) was similar 
to or higher than those in WT animals (433 ± 90 and 258 ± 
40 cells/µl, respectively; n = 4). No infiltration of monocytes/
macrophages identified as Ly6GCD11b+ cells could be ob-
served in the synovial area of Hck/Fgr/Lyn/ mice ei-
ther (Fig. 4 E; P = 0.015 and 0.031 for ankle and front paw, 
respectively; n = 6; this could not be tested in CD18/ mice 
because their leukocytes do not express CD11b). Collectively, 
similar to the CD18 deficiency, the Hck/Fgr/Lyn/ 
mutation also abrogates the accumulation of myeloid cells at 
the site of inflammation.
No cell-autonomous migration defect  
in Hck/Fgr/Lyn/ myeloid cells
To reveal whether the defective leukocyte recruitment in 
Hck/Fgr/Lyn/ mice is due to a cell-autonomous migra-
tion defect, we directly compared the accumulation of WT and 
mutant cells within the same animal. To this end, we generated 
mixed bone marrow chimeras carrying varying ratios of CD45.1-
expressing WT, along with CD45.2-positive WT, CD18/, 
or Hck/Fgr/Lyn/ hematopoietic cells within the same 
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Figure . Normal in vitro and in vivo migration of Hck/Fgr/Lyn/ neutrophils. (A–G) Mixed bone marrow chimeras with CD45.1-expressing WT 
and CD45.2-expressing WT, CD18/ (CD18 KO), or Hck/Fgr/Lyn/ (3× SFK KO) hematopoietic cells were subjected to K/B×N serum transfer arthritis as 
described in the Fig. 1 legend. In vivo accumulation of neutrophils (PMN; A–D and F) and monocytes/macrophages (Mono/M; E and G) was determined by 
flushing the synovial area of arthritic serum-treated mixed bone marrow chimeras on day 4, followed by flow cytometric analysis of the ratio of CD45.1- and 
CD45.2-expressing cells in peripheral blood and the synovial infiltrate. A–C shows representative histograms of CD45.2 expression in blood or synovial neu-
trophils. In D and E, each dot represents an individual mouse. Bar graphs in F and G show mean and SEM of relative migration. Data are representative of  
(A–C) or summarize (D and F) data obtained from 7–26 mice per group from 3–9 independent experiments or 7–14 mice per group from 3–5 independent 
experiments (E and G). (H and I) In vitro migration of CD18/ and Hck/Fgr/Lyn/ bone marrow neutrophils (H) and monocytes (I) toward the indicated 
chemoattractants in a fibrinogen-coated Transwell system. Data represent mean and SEM of 3–13 (H) or 3–5 (I) independent experiments.
neutrophil migration toward fMLP (which mimics bacterial/ 
mitochondrial-derived signals) was strongly reduced in CD18/ 
(P = 4.1 × 104; n = 4) but not in Hck/Fgr/Lyn/ cells 
(P = 0.17; n = 4). Similarly, neutrophil migration toward the 
lipid chemoattractant LTB4 was dependent on CD18 (P = 1.7 × 
106; n = 3) but was not affected by the Hck/Fgr/Lyn/ 
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in vitro migration of neutrophils and monocytes toward major 
proinflammatory chemoattractants does not depend on Hck, 
Fgr, or Lyn irrespective of the requirement for 2 integrins in 
the given assay.
Defective generation of the inflammatory environment
The above observations could be explained by a role for my-
eloid Src family kinases in the generation of the inflammatory 
environment. As shown in the cytokine arrays in Fig. 6 A (see 
array map in Fig. 6 B and quantification in Table S1), K/B×N 
serum transfer arthritis triggered robust accumulation of vari-
ous inflammatory mediators in the synovial tissue of WT but 
not Hck/Fgr/Lyn/ animals. Prior studies suggested 
important roles for IL-1, keratinocyte chemoattractant (KC; 
CXCL1), MIP-1, MIP-2, and LTB4 in myeloid cell infil-
tration during autoantibody-induced inflammation (Kim 
et al., 2006; Chou et al., 2010; Jacobs et al., 2010), whereas 
MCP-1 is considered a major monocyte chemoattractant 
(Deshmane et al., 2009). ELISA assays (Fig. 6 C) confirmed 
mutation (P = 0.41; n = 4). Interestingly, migration of neutrophils 
toward macrophage inflammatory protein 2 (MIP-2; CXCL2), 
a distant homologue of human IL-8, was not affected by either 
the CD18/ (P = 0.58; n = 9) or the Hck/Fgr/Lyn/ 
(P = 0.39; n = 7) mutation.
We have also tested the in vitro migration of freshly iso-
lated bone marrow monocytes (Fig. 5 I). Monocyte migration 
toward leukotriene B4 (LTB4) was abrogated by CD18 defi-
ciency (P = 0.0038; n = 3) but not by the Hck/Fgr/Lyn/ 
mutation (P = 0.93; n = 5). Migration of monocytes toward 
MIP-1 (CCL3), one of the major monocyte chemoattrac-
tants, was also moderately reduced by the CD18/ mutation 
with a borderline statistical significance (P = 0.057; n = 3), 
but it was normal in Hck/Fgr/Lyn/ cells (P = 0.63; 
n = 5). The migration of the cells toward monocyte chemoat-
tractant protein 1 (MCP-1; CCL2), another major monocyte 
chemoattractant, was slightly even increased by CD18 defi-
ciency (P = 0.0039; n = 3), but it was not affected by the 
Hck/Fgr/Lyn/ mutation (P = 0.74; n = 5). Collectively, 
Figure . Myeloid Src family kinases are required for the generation of an inflammatory environment in vivo. Intact WT or Hck/Fgr/Lyn/  
(3× SFK KO) mice were subjected to K/B×N serum transfer arthritis as described in the legend to Fig. 1. (A and C) The synovial area was flushed on Day 4. The cell-free 
supernatants of the synovial infiltrates were probed using a commercial cytokine array (A) or by ELISA assays for the indicated pro-inflammatory mediators (C).  
(B) Map of the position of the different analytes on the cytokine array. A shows representative images from 2 independent experiments, whereas C shows mean 
and SEM of 4–6 mice per group from 3–5 independent experiments. (D-E) MPO activity was determined in vivo by chemiluminescence imaging after i.p. injection 
of luminol. Color-coded photon flux intensity is superposed on the grayscale photo of the mouse (D) and quantitated in defined regions of interest (E). Represen-
tative images (D) and mean and SEM (E) from 4 control and 6 arthritic serum-treated mice per genotype from 2 independent experiments are shown.
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Hck/Fgr/Lyn/ myeloid cells fail  
to respond to immune complex stimulation
To test whether Src family kinases are directly involved in the gen-
eration of an inflammatory environment, we investigated immune 
complex–induced in vitro responses of neutrophils and macro-
phages. As shown in Fig. 7 (A and B), the Hck/Fgr/Lyn/ 
mutation completely blocked immune complex–induced su-
peroxide release from neutrophils (P = 2.4 × 1021; n = 15). 
Similar to the in vivo findings with K/B×N serum transfer 
arthritis (Fig. 2), the Hck/Lyn/ mutation caused a partial 
but statistically significant reduction (P = 5.8 × 104; n = 4; 
this may in part be due to increased basal levels in those sam-
ples), whereas the other single or double knockouts had no 
significant defect (Fig. 7, A and B; 0.10 < P < 0.71; n = 3).
As shown in the cytokine arrays in Fig. 7 C (see array map in 
Fig. 6 B and quantification in Table S1), immune complex stim-
ulation also triggered the release of several cytokines and che-
mokines from WT but not Hck/Fgr/Lyn/ neutrophils. 
that the Hck/Fgr/Lyn/ mutation abrogated the up-
regulation of IL-1 (P = 0.0026; n = 5), KC (P = 9.0 × 107; 
n = 5), MCP-1 (P = 0.0014; n = 5), MIP-2 (P = 0.023; n = 6), 
and LTB4 (P = 7.4 × 1015; n = 3) in the synovial tissue and 
caused a substantial (though not statistically significant) reduc-
tion of MIP-1 levels (P = 0.095; n = 4).
We have also tested the generation of reactive oxygen spe-
cies (ROS) and the release of granule enzymes into the extra-
cellular space at the inflammatory site by in vivo imaging of 
the activity of myeloperoxidase (MPO), a neutrophil granule-
derived ROS-producing enzyme (Gross et al., 2009; Nussbaum 
et al., 2013). As shown in Fig. 6 (D and E), K/B×N serum 
transfer arthritis triggered a robust ROS bioluminescence 
signal localized to the ankles and front paws in WT but not 
Hck/Fgr/Lyn/ mutant animals (P = 0.010; n = 6). Col-
lectively, myeloid Src family kinases are required for various 
aspects of the generation of a proinflammatory environment 
during autoantibody-induced arthritis.
Figure . Hck/Fgr/Lyn/ neutrophils fail to respond to immune complex stimulation. WT, Hck/Fgr/Lyn/ (3× SFK KO), and the various sin-
gle and double knockout neutrophils were placed on immobilized immune complex (IC) surfaces. Superoxide release (A and B) was followed by a spectrophoto-
metric assay. Cytokine, chemokine, and lipid mediator levels in cell-free supernatants were determined after an incubation for 1 h (LTB4) or 6 h (all other 
readouts) using a commercial cytokine array (C) or ELISA assays (D). Graphs in A and B show mean and SEM of 3–22 independent experiments per genotype. 
Values at the zero time point were subtracted. C is representative of 2 independent experiments. D shows mean and SEM from 4–11 independent experiments.
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Lowell, 1998; Mócsai et al., 1999; Suen et al., 1999; Fitzer-
Attas et al., 2000; Pereira et al., 2001; Lowell, 2004). Our above 
observations led us to reevaluate this issue.
ELISA assays revealed that the Hck/Fgr/Lyn/ mutation 
dramatically reduced or even completely abrogated the im-
mune complex–induced release of IL-1 (P = 5.1 × 105; n = 6), 
KC (P = 3.6 × 105; n = 6), MIP-1 (P = 5.0 × 106; n = 6), 
MIP-2 (P = 4.8 × 1015; n = 11), and LTB4 (P = 8.8 × 105; 
n = 4) from neutrophils (Fig. 7 D), whereas no release of MCP-1 
could be observed even from WT cells (not depicted).
We also tested the immune complex–induced responses 
of bone marrow–derived macrophages. As shown in Fig. 8 A, 
the Hck/Fgr/Lyn/ mutation completely blocked im-
mune complex–induced ROS production by macrophages 
(P = 2.8 × 108; n = 4). The cytokine arrays shown in Fig. 8 B 
(see array map in Fig. 6 B and quantification in Table S1) in-
dicated immune complex–induced release of various pro-
inflammatory cytokines from WT macrophages which was 
strongly reduced in Hck/Fgr/Lyn/ cultures. ELISA 
assays (Fig. 8 C) confirmed that the Hck/Fgr/Lyn/ 
mutation strongly inhibited the immune complex–induced re-
lease of KC (P = 0.0013; n = 5), MCP-1 (P = 0.010; n = 4), and 
TNF (P = 4.0 × 104; n = 4) from macrophages, caused a 
partial but statistically significant inhibition of MIP-2 release 
(P = 0.027; n = 4), and led to an apparent reduction of MIP-
1 release which, however, did not reach statistical significance 
(P = 0.29; n = 4). In contrast, no release of IL-1 or LTB4 could 
be observed even in WT cultures (unpublished data). Collectively, 
the genetic deficiency of Hck, Fgr, and Lyn blocks the immune 
complex–induced release of various components of the inflam-
matory environment from both neutrophils and macrophages.
Src family kinases are required for initial  
Fc receptor signaling in neutrophils
Prior studies indicated that Src family kinases are critically in-
volved in integrin- but not Fc receptor–mediated functional 
responses of myeloid cells (Lowell et al., 1996; Meng and 
Figure 8. Defective responses of Hck/Fgr/Lyn/ macrophages to immune complex stimulation. Bone marrow–derived WT or Hck/Fgr/Lyn/ 
(3× SFK KO) macrophages were placed on immobilized immune complex (IC) surfaces. Their superoxide release (A) was followed by a luminometric assay. Cytokine 
and chemokine levels from the cell-free supernatants taken after 24 h were tested by a commercial cytokine array (B) or by ELISA assays (C). A shows mean and 
SEM from 4 independent experiments. B is representative of 2 experiments. C shows mean and SEM of data from 4–5 independent experiments.
Figure 9. Src family kinases are required for immune complex–induced 
phosphorylation of FcR and Syk. (A–C) WT or Hck/Fgr/Lyn/  
(3× SFK KO) neutrophils were plated on immobilized IgG immune 
complexes (IC). Cell lysates were subjected to a GST pulldown assay  
(A and B) using either WT or R41A/R194A double mutant (SH2-Dead) GST-
Syk(SH2)2 fusion protein and probed for the presence of FcR by Western 
blotting (WB), or processed for Syk immunoprecipitation (IP), followed by 
immunoblotting for phosphotyrosine (PY) or Syk as a loading control (C). 
Whole cell lysates (WCL) served as loading control in A and B. Blots in A–C 
are representative of 3 independent experiments. Note substantial mobil-
ity shift caused by the tyrosine phosphorylation of FcR homodimers 
under the used nonreducing (NR) conditions in A and B. WB, Western blot.
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no such signal could be observed upon functional disruption 
of both SH2 domains (Mócsai et al., 2006), indicating that 
this assay specifically detects phosphorylation of the FcR 
ITAM tyrosines. Importantly, no FcR phosphorylation 
could be observed in lysates of immune complex–stimulated 
Hck/Fgr/Lyn/ neutrophils (Fig. 9 B).
We first tested the phosphorylation of the Fc receptor 
-chain (FcR), the ITAM-containing signaling chain of 
activating Fc receptors. As shown in Fig. 9 A, a glutathione 
S-transferase (GST) fusion protein of the tandem SH2 domains 
of Syk (GST-Syk(SH2)2) was able to pull down FcR from 
lysates of immune complex–activated WT neutrophils, whereas 
Figure 0. FcR deficiency phenocopies the deficiency of Src family kinases. (A–C) K/B×N serum transfer arthritis was induced in intact WT and 
FcR/ mice as described in the Fig. 1 legend, followed by analysis of the clinical disease course as described in Fig. 1 A (3 control and 5–7 arthritic mice per 
genotype from 3 independent experiments) or the quantification of leukocyte infiltration as described in Fig. 4 (B and C; 2–3 control and 6 arthritic mice per 
genotype from 3 independent experiments). (D and E) In vivo migration of neutrophils (PMN) and monocytes/macrophages (Mono/M) determined using 
mixed bone marrow chimeras containing CD45.1-expressing WT and CD45.2-expressing FcR/ cells as described in Fig. 5. Each dot in D represents an indi-
vidual mouse. E shows mean and SEM of relative migration. (D and E) Data were obtained from 6–8 mice per group from 3 independent experiments.  
(F) In vitro migration of WT and FcR/ neutrophils tested as described in Fig. 5. Data were obtained from 3 independent experiments. (G) Inflammatory 
mediator release from WT and FcR/ mice determined as described in Fig. 6. Data were obtained from 3–5 mice per group from 3 independent experiments.  
(H and I) Superoxide (H) or cytokine/chemokine/lipid mediator (I) release from immune complex-activated WT and FcR/ neutrophils from intact mice was 
determined as described in Fig. 7. Data were obtained from 4 (H) or 3 (I) independent experiments. (J) Bone marrow chimeras generated by transplanting 
FcR/ or CD45.1-expressing WT bone marrow cells mixed with Hck/Fgr/Lyn/ cells at varying ratios were subjected to K/B×N serum transfer arthritis 
as described in Fig. 1. Area under the curve (AUC) values for daily clinical scoring and ankle thickness measurements are shown in relation to the percentage 
of WT or FcR/ (i.e., non-Hck/Fgr/Lyn/) cells in the peripheral blood. Data represent results from 8–13 control and 28–32 arthritic serum-treated 
mice per group from 3 independent experiments. All error bars show SEM from the indicated number of mice or experiments.
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restored arthritis development. Obvious arthritis was clearly seen 
at 50% WT neutrophils in the circulation and the severity of 
arthritis further increased with increasing percentage of WT 
cells. In contrast, mixing Hck/Fgr/Lyn/ and FcR/ 
hematopoietic tissues did not result in any signs of arthritis de-
velopment in the resulting chimeras at any ratio of the two geno-
types in the circulating neutrophil pool. Collectively, the in vivo 
and in vitro phenotypes of Hck/Fgr/Lyn/ and FcR/ 
mutants are strikingly similar and FcR/ cells cannot restore 
arthritis development on the Hck/Fgr/Lyn/ back-
ground, suggesting a functional overlap between Src family 
kinases and Fc receptors.
DISCUSSION
Our experiments have revealed complete protection of 
Hck/Fgr/Lyn/ mice from K/B×N serum transfer arthri-
tis, autoantibody-induced skin blistering, and the reverse passive 
Arthus reaction (Figs. 1 and 3). Hck, Fgr, and Lyn were required 
in the hematopoietic compartment (Fig. 1, E–H) and showed 
significant functional overlap with each other (Fig. 2).
The overall phenotype of Hck/Fgr/Lyn/ mutants 
was very similar to that of 2 integrin–deficient (CD18/) 
mice (Watts et al., 2005; Liu et al., 2006; Chiriac et al., 2007; 
Németh et al., 2010). 2 integrins have long been known to me-
diate leukocyte migration to the site of inflammation (Mizgerd 
et al., 1997; Scharffetter-Kochanek et al., 1998; Walzog et al., 
1999; Schymeinsky et al., 2007). Indeed, we observed a complete 
defect of leukocyte infiltration into the synovial tissue of 
CD18/ animals (Fig. 4), and our mixed bone marrow chime-
ric experiments (Fig. 5, A–G) indicated, in agreement with a 
prior report (Monach et al., 2010), that CD18/ myeloid cells 
had a cell-autonomous leukocyte migration defect. The simi-
larities of the CD18/ and Hck/Fgr/Lyn/ phenotypes 
and the defective leukocyte infiltration in Hck/Fgr/Lyn/ 
mice (Fig. 4) suggested that Hck/Fgr/Lyn/ leukocytes 
have an intrinsic migration defect. However, Hck/Fgr/Lyn/ 
myeloid cells accumulated normally in the inflamed synovium 
in mixed bone marrow chimeras (Fig. 5, A–G) and showed no 
in vitro migration defects either (Fig. 5, H and I). In con-
trast, they failed to release inflammatory mediators when ac-
tivated by immobilized immune complexes in vitro (Fig. 7 
and 8). Therefore, the arthritis defect in Hck/Fgr/Lyn/ 
mice is likely due to the defective generation of an inflam-
matory environment rather than, as initially expected, to 
a cell-autonomous defect of 2 integrin–mediated leuko-
cyte migration.
Our results, in agreement with prior studies (Kim et al., 
2006; Chen et al., 2006; Chou et al., 2010), indicate the exis-
tence of positive-feedback loops acting through the release of 
proinflammatory mediators (including IL-1, neutrophil and 
monocyte/macrophage chemokines, and LTB4) from myeloid 
cells that attract further myeloid cells to the site of inflammation. 
2 integrins and Src family kinases apparently function at dif-
ferent points of the feedback loop; whereas the former are re-
quired for the intrinsic migratory ability of leukocytes, the 
latter are involved in the release of proinflammatory mediators. 
We next tested the activation of the Syk tyrosine kinase. 
As shown in Fig. 9 C, immune complex–induced neutrophil 
activation led to tyrosine phosphorylation of Syk in WT but 
not Hck/Fgr/Lyn/ neutrophils. The above results in-
dicate an indispensable role for Src family kinases in receptor-
proximal Fc receptor signaling in neutrophils.
FcR deficiency recapitulates the phenotypes  
of Hck/Fgr/Lyn/ mutants
The apparent role of Src family kinases in Fc receptor signaling 
prompted us to test the deficiency of FcR/ mice (which 
lack all activating Fc receptors; Takai et al., 1994; Bruhns, 2012) 
in more detail. In agreement with previous studies ( Ji et al., 
2002; Corr and Crain, 2002), FcR/ mice were completely 
protected from clinical signs of arthritis development in the 
K/B×N serum transfer model (Fig. 10 A; P = 0.0033 and 
0.0039 for clinical score and ankle thickness, respectively; n = 5).
As shown in Fig. 10 (B and C), no accumulation of neu-
trophils (P = 0.028; n = 6) or of monocytes/macrophages de-
fined either as Ly6GF4/80+ (P = 0.040; n = 6) or Ly6GCD11b+ 
(P = 0.042; n = 6) cells could be observed in the ankle 
synovium in FcR/ mice. In contrast, in mixed bone mar-
row chimeras where WT hematopoietic cells were also pres-
ent (Fig. 10, D and E), the FcR/ mutation did not affect 
the accumulation of neutrophils (P = 0.27; n = 8) or macro-
phages (P = 0.13; n = 8) in the synovial tissue (normalized to 
the percentage of circulating FcR/ neutrophils and mono-
cytes, respectively). FcR/ neutrophils also migrated nor-
mally toward fMLP, LTB4, and MIP-2 in vitro (Fig. 10 F; 0.42 < 
P < 0.46; n = 3).
We also tested typical components of the inflammatory 
environment. FcR deficiency prevented the increase of IL-
1 (P = 0.017; n = 5), KC (P = 0.026; n = 5), MCP-1 (P = 1.5 × 
105; n = 4), MIP-1 (P = 0.023; n = 3), MIP-2 (P = 0.025; 
n = 4), and LTB4 (P = 0.016; n = 5) in the synovial tissue of 
K/B×N serum-treated mice (Fig. 10 G and not depicted). As 
reported before (Jakus et al., 2008), FcR/ neutrophils 
failed to release superoxide when plated on an immobilized 
IgG immune complex surface in vitro (Fig. 10 H; P = 7.4 × 
105; n = 4). FcR deficiency also completely blocked the im-
mune complex–induced release of IL-1 (P = 0.0020; n = 3), 
KC (P = 0.038; n = 3), MIP-1 (P = 0.031; n = 3), MIP-2 
(P = 5.2 × 104; n = 3), and LTB4 (P = 0.013; n = 3) from 
neutrophils (Fig. 10 I and not depicted).
All the above experiments indicated that the Hck/Fgr/ 
Lyn/ and the FcR/ mutations cause similar phenotypes 
in our in vitro and in vivo models of autoantibody-induced 
inflammatory reactions. To provide further evidence for the 
functional overlap between Src family kinases and FcR, we 
tested whether FcR/ hematopoietic cells can rescue ar-
thritis development in Hck/Fgr/Lyn/ mutants. To this 
end, we generated mixed bone marrow chimeras carrying 
Hck/Fgr/Lyn/ hematopoietic system mixed with WT 
or FcR/ hematopoietic cells, and we tested arthritis develop-
ment in those chimeras. As shown in Fig. 10 J, the presence of 
WT hematopoietic tissues in addition to Hck/Fgr/Lyn/ 
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Nevertheless, due to the nature of autoamplification loops, 
the CD18/ and the Hck/Fgr/Lyn/ mutations both 
abrogate the entire inflammation process.
Although several prior reports proposed important roles 
for Src family kinases in in vitro (Fumagalli et al., 2007; Sarantos 
et al., 2008) and in vivo (Lowell and Berton, 1998; Meng and 
Lowell, 1998; Vicentini et al., 2002) migration of myeloid cells, 
several other studies came to the opposite conclusion (Mócsai 
et al., 2002; Zhang et al., 2005; Hirahashi et al., 2006; Yoo 
et al., 2011). The interpretation of those studies is hindered by 
their limited scope (Lowell and Berton, 1998; Sarantos et al., 
2008), apparently contradicting results (Meng and Lowell, 
1998; Mócsai et al., 2002; Zhang et al., 2005), indications of 
indirect effects on leukocyte migration (Vicentini et al., 2002), or 
defects seen only in unique in vitro assay systems (Fumagalli 
et al., 2007; Sarantos et al., 2008). Though our studies confirm 
the overall requirement for Src family kinases in leukocyte 
migration to the site of inflammation (Fig. 4), we conclude 
that this is not due to an intrinsic migration defect but to de-
fective generation of the inflammatory environment. We never-
theless believe that certain specific in vitro conditions (such as 
very narrow Transwell pore sizes, transmigration through tightly 
sealed endothelial monolayers, or truly two-dimensional assays) 
may favor leukocyte migration in a Src family–dependent 
manner. In this context, it is interesting to note that dasatinib, 
an inhibitor of Src family kinases, blocked human neutrophil 
migration in a two-dimensional Zigmond chamber assay but 
not in various three-dimensional assays (Futosi et al., 2012). 
Similarly, the Hck/Fgr/Lyn/ mutation partially reduced 
(but did not abrogate) neutrophil migration toward fMLP in 
a two-dimensional Zigmond chamber assay but not within a 
three-dimensional collagen gel (Barbara Walzog, personal com-
munication). Further internally controlled in vivo experiments 
and detailed imaging studies, as well as analysis of other (e. g. 
microbial) chemotactic agents, will be needed to reveal the full 
spectrum of the contribution (or the lack of contribution) of Src 
family kinases to in vitro and in vivo migration of myeloid cells.
Several studies indicated a critical role for Src family ki-
nases in 2 integrin–mediated neutrophil and macrophage 
activation (Lowell et al., 1996; Mócsai et al., 1999; Suen et al., 
1999; Giagulli et al., 2006). In agreement with those studies, 
both CD18/ and Hck/Fgr/Lyn/ neutrophils failed 
to adhere to an ICAM1-coated surface (unpublished data). 
This is in sharp contrast to the normal 2 integrin–mediated 
migration of Hck/Fgr/Lyn/ neutrophils and macro-
phages (Fig. 5). Though those results suggest that Src family–
mediated outside-in signaling of 2 integrins and the resulting 
cellular responses (e.g., cell spreading) are not required for 2 
integrin–mediated leukocyte migration, additional studies will 
be needed to fully clarify that issue.
It should also be mentioned that a prior study revealed 
integrin-independent leukocyte migration in three-dimensional 
environments (Lämmermann et al., 2008). Though it would 
be tempting to speculate that the normal in vivo recruitment 
of Hck/Fgr/Lyn/ myeloid cells in mixed bone marrow 
chimeras is due to such integrin-independent mechanisms, 
the clear cell-autonomous requirement for CD18 (Fig. 5, 
A–G) indicates that this is not the case. Eosinophils comprised 
19 ± 4% of circulating granulocytes but only 1.1 ± 0.7% of 
granulocytes in the synovial infiltrate (n = 5 mice per group), and 
eosinophil-deficient mice were even hyperresponsive in K/B×N 
serum transfer arthritis (Chen et al., 2014). Despite some con-
troversy (Lee et al., 2002; Zhou et al., 2007; Feyerabend et al., 
2011), our current understanding is that mast cells and basophils 
do not make a substantial contribution to autoantibody-induced 
arthritis either. Those points argue against a major contribution 
of eosinophils and mast cells/basophils to autoantibody-induced 
inflammation and the Hck/Fgr/Lyn/ phenotype.
Concerning how Src family kinases participate in the gener-
ation of the inflammatory environment, our biochemical stud-
ies (Fig. 9, A–C) suggest that the Hck/Fgr/Lyn/ mutation 
abrogates proximal signal transduction by activating Fc re-
ceptors. This is further supported by the similarities between 
the Hck/Fgr/Lyn/ and FcR/ mutants (Fig. 10, A–I) 
and the lack of rescue of the Hck/Fgr/Lyn/ arthritis 
phenotype by FcR/ hematopoietic cells (Fig. 10 J). As Fc 
receptors are also required for autoantibody-induced skin blis-
tering disease (Sitaru et al., 2002, 2005), this may also explain 
the protection of Hck/Fgr/Lyn/ mice in that model 
(Fig. 3, A–C).
Our results (Figs. 7–10) argue against prior assumptions 
that Src family kinases do not play a major role in Fc receptor 
signaling in myeloid cells (Lowell et al., 1996; Fitzer-Attas 
et al., 2000; Lowell, 2004). In case of neutrophils, Lyn ap-
pears to compensate for the lack of the other two kinases in 
Hck/Fgr/ cells; therefore, a dramatic effect is only observed 
in Hck/Fgr/Lyn/ triple mutants (Fig. 7, A and B). In 
case of macrophages, the apparent contradiction may stem from 
a similar compensation by another Src family kinase (e. g. Src or 
Yes), or by different signals required for Fc receptor–mediated 
phagocytosis and responses to immobilized immune complexes.
An additional level of complexity may derive from a po-
tential role for 2 integrins in immune complex–induced ac-
tivation of myeloid cells. In agreement with a prior study 
(Chen et al., 2003), we observed partial reduction of immune 
complex–induced functional responses of CD18/ neutro-
phils which, however, was not nearly as pronounced as the 
complete defect seen in Hck/Fgr/Lyn/ and FcR/ 
cells (unpublished data). Analysis of CD11a/ and CD11b/ 
mice revealed that the partial reduction of immune complex–
induced neutrophil responses was mediated by Mac-1 (CD11b/
CD18) rather than LFA-1 (CD11a/CD18), whereas, in agree-
ment with prior studies (Watts et al., 2005; Monach et al., 
2010), in vivo arthritis was primarily mediated by LFA-1 but 
not Mac-1 (unpublished data). In agreement with prior reports 
suggesting a negative role for Mac-1 in various neutrophil- 
and autoantibody-mediated inflammatory diseases (Watts 
et al., 2005; Rosetti et al., 2012), Mac-1–deficient (CD11b/) 
mice were even hyperresponsive in the K/B×N serum trans-
fer model (unpublished data). Furthermore, although 2  
integrin–mediated responses are primarily mediated by Hck 
and Fgr (Lowell et al., 1996; Mócsai et al., 1999; Suen et al., 
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and FcR/ donor bone marrow cells in the range of 1:3 to 3:1 ratios. The 
percentage of the two genotypes in the Ly6G-positive granulocyte gate in 
the resulting chimeras was tested by flow cytometry using an Alexa Fluor 
647–conjugated antibody (clone 9E9; provided by F. Nimmerjahn, Erlangen, 
Germany) against mouse FcRIV which is not expressed on FcR/ neu-
trophils (Nimmerjahn et al., 2005). Generation and analysis of mixed bone 
marrow chimeras for competitive migration experiments is described below.
K/B×N serum transfer arthritis. Mice carrying the KRN T cell receptor 
transgene on the C57BL/6 genetic background were mated with NOD 
mice to obtain transgene-positive (arthritic) K/B×N and transgene-negative 
(nonarthritic) B×N mice (Kouskoff et al., 1996; Jakus et al., 2009). The pres-
ence of the transgene was determined by allele-specific PCR and confirmed 
by phenotypic assessment. Blood was taken by retro-orbital bleeding and sera 
from arthritic and control mice were pooled separately.
Arthritis was induced by intraperitoneal injection of 300 µl K/B×N 
(arthritic) or B×N (control) serum into intact mice or bone marrow chime-
ras, followed by daily assessment of arthritis severity for 2 wk as previously 
described (Jakus et al., 2009). Visible clinical signs were scored on a 0–10 scale 
by two investigators blinded for the origin and treatment of the mice. Ankle 
thickness was measured by a spring-loaded caliper (Kroeplin). For histologi-
cal analysis, mice were sacrificed 7 d after serum transfer, their ankles were 
fixed in formalin, decalcified, embedded in paraffin, sectioned at 5 µm thick-
ness, and stained with hematoxylin and eosin (Helyes et al., 2004). Images 
were captured with an inverted microscope (DMI 6000B; Leica) using a 5× 
objective in transmitted light mode.
To assess articular function, mice were placed on a custom-made (Charles 
River Hungary) wire grid, slowly flipped, and the length of time the mice 
held on to the grid was recorded as previously described (Jakus et al., 2009). 
This test was performed 3 times daily during the period of 6–12 d after the 
serum injection. The obtained data were combined into “holding-on curves” 
for each mouse.
In vivo imaging of ROS production. A luminol chemiluminescence assay 
was used to detect in vivo MPO activity (Gross et al., 2009). Mice were anaes-
thetized with 50 mg/kg pentobarbital sodium i.p. and injected i.p. with 150 mg/kg 
luminol sodium salt (Sigma-Aldrich) dissolved in PBS. Luminescence images 
were captured 10 min after the injection with an IVIS Lumina II imaging sys-
tem (PerkinElmer) and processed using the Living Image software (PerkinElmer). 
Total radiance values (total photon flux/s) from standardized regions of inter-
est of front and hind paws were used for quantitative analysis.
Autoantibody-induced skin blistering model. The murine model of the 
human autoantibody-induced blistering skin disease epidermolysis bullosa 
acquisita was triggered by systemic administration of antibodies against colla-
gen VII (Sitaru et al., 2005). GST fusion proteins containing the mCVIICr 
fragment of mouse collagen VII were expressed in E. coli, purified using GST 
affinity columns, and used to generate polyclonal antiserum in rabbits as pre-
viously described (Csorba et al., 2010). The IgG fraction of the antiserum was 
prepared using a Protein G Sepharose Fast Flow affinity column chromatog-
raphy (GE Healthcare) as previously described (Sitaru et al., 2005). The reac-
tivity of the antibody preparation was tested using an ELISA with His-tagged 
mCVIICr fragment of murine collagen VII, as well as by indirect immuno-
fluorescence on mouse skin sections as previously described (Csorba et al., 
2010). Normal rabbit IgG (Sigma-Aldrich) was used as control.
15 mg pathogenic or control IgG per mouse was injected subcutane-
ously under isoflurane anesthesia on days 0 and 2,  followed by 10 mg IgG/
mouse on days 4, 6, and 8 (60 mg total IgG/mouse). The disease onset and 
progression was followed by clinical assessment and photodocumentation 
every two days. Scoring was based on the specific dermatological abnormali-
ties (e.g., erythema, blister, crust) and the size of the affected skin area, with 
the latter determined using predefined percentages of the various areas of the 
skin of mice (e.g., one ear: 2.5%; snout: 5%; etc.). Antibody levels against col-
lagen VII in blood samples at day 6 were determined by ELISA.
1999), autoantibody-induced arthritis primarily relies on Hck 
and Lyn (Fig. 2). Those points together suggest that the amplifi-
cation of immune complex–induced neutrophil responses by 2 
integrins (primarily Mac-1) is unlikely to substantially contribute 
to the in vivo arthritis defect in Hck/Fgr/Lyn/ mice.
Collectively, our experiments have revealed a critical role 
for Src family kinases in various myeloid cell–mediated animal 
models of human disease. The role of Src family kinases was 
related to the immune complex–induced generation of an 
inflammatory microenvironment, revealing a so-far underesti-
mated role for Src family kinases in the inflammatory response. 
Those results may contribute to the understanding, diagnosis, 
and therapy of major human diseases such as rheumatoid ar-
thritis and inflammatory skin diseases.
MATERIALS AND METHODS
Animals. Mice homozygous for the Hcktm1Hev, Fgrtm1Hev, or Lyntm1Sor mutations 
(referred to as Hck/, Fgr/, or Lyn/ mice, respectively) were described 
before (Lowell et al., 1994; Chan et al., 1997). Single, as well as combined dou-
ble and triple knockout strains were maintained in homozygous form, except 
for the Hck/Lyn double mutation which was maintained in Hck/Lyn+/ 
form due to the limited viability of Hck/Lyn/ mice (Xiao et al., 2008). It 
should be noted that although Hck/Lyn/ double knockout mice were of 
poor overall health and died within 2 mo after birth, Hck/Fgr/Lyn/ tri-
ple knockouts were apparently healthy and bred normally in homozygous 
form, indicating that the severe myeloproliferation reported in Hck/Lyn/ 
mice (Xiao et al., 2008) is somehow mediated by the Fgr kinase.
Complete CD18-deficient (Itgb2tm2Bay/tm2Bay, referred to as CD18/) mice 
(Scharffetter-Kochanek et al., 1998) were obtained from A. Beaudet (Baylor 
College of Medicine, Houston, TX). CD11a-deficient (Itgaltm1Hogg/tm1Hogg, re-
ferred to as CD11a/) mice (Berlin-Rufenach et al., 1999) were obtained 
from N. Hogg (Cancer Research UK, London, UK). CD11b-deficient 
(Itgamtm1Myd/tm1Myd, referred to as CD11b/) mice (Coxon et al., 1996) were 
purchased from The Jackson Laboratory. FcR-deficient (Fcer1gtm1Rav/tm1Rav, 
referred to as FcR/) mice (Takai et al., 1994) were purchased from Ta-
conic. Mice carrying the KRN T cell receptor transgene (Tg(TcraR28,Tcrb
R28)KRNDim; Kouskoff et al., 1996) were obtained from D. Mathis and C. 
Benoist (Harvard Medical School, Boston, MA) and maintained in heterozy-
gous form by mating with C57BL/6 mice.
All transgenic mice were backcrossed to the C57BL/6 genetic back-
ground for at least 6 generations. Genotyping was performed by allele-specific 
PCR. WT control C57BL/6 mice were purchased from Charles River or the 
Hungarian National Institute of Oncology. NOD mice, as well as a congenic 
strain carrying the CD45.1 allele on the C57BL/6 genetic background (B6.
SJL-Ptprca), were purchased from The Jackson Laboratory. Mice were kept in 
individually sterile ventilated cages (Tecniplast) in a conventional facility. All 
animal experiments were approved by the Animal Experimentation Review 
Board of the Semmelweis University or the University of Pécs.
Bone marrow chimeras were generated by intravenous injection of un-
fractionated bone marrow cells into recipients carrying the CD45.1 allele on 
the C57BL/6 genetic background, which were lethally irradiated before by 
11.5 Gy from a 137Cs source using a Gamma-Service Medical D1 irradiator. To 
test the role of Hck, Fgr, and Lyn in the nonhematopoietic compartment, 
Hck/Fgr/Lyn/ mice were irradiated and transplanted with CD45.1-
expressing WT donor bone marrow cells. 3–6 wk after transplantation, peripheral 
blood samples were stained for Ly6G and CD45.2 and analyzed by flow cytome-
try (see below). Repopulation of the hematopoietic compartment by donor-
derived cells was defined as the percentage of donor-derived cells in the 
Ly6G-positive granulocyte gate. Bone marrow chimeras were used 4–10 wk after 
the transplantation, except for Hck/Lyn/ chimeras which, due to their re-
ported health issues (Xiao et al., 2008), were used 3–5 wk after transplantation.
Mixed bone marrow chimeras carrying Hck/Fgr/Lyn/ and FcR/ 
cells were generated as described above using a mixture of Hck/Fgr/Lyn/ 
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Ca2+- and Mg2+-free medium until use (usually less than 30 min) and pre-
warmed to 37°C before activation. Neutrophil assays were performed at 
37°C in HBSS supplemented with 20 mM Hepes, pH 7.4.
Mouse bone marrow-derived macrophages were obtained by culturing 
bone marrow cells from intact mice in -MEM (Sigma) complemented with 
10% FCS (Invitrogen), 2 mM l-glutamine, antibiotics, 10 mM HEPES (all 
from Sigma-Aldrich), and 10% conditioned medium from CMG 14–12 cells 
as a source of recombinant murine M-CSF (Kertész et al., 2012) for 8–10 d on 
bacterial Petri dishes with media changes every 2–3 d. Cells were suspended by 
5 mM EDTA, washed and serum-starved for 2 h before the experiments.
Mouse monocytes were isolated from the bone marrow of femurs and 
tibias of intact mice using a CD115 MicroBead kit (Miltenyi Biotec), followed 
by magnetic separation on LS columns (Miltenyi Biotec) according to the 
manufacturer’s instructions. Sample purity was >95% as tested by flow cytom-
etry using F4/80 and Ly6G staining. In vitro monocyte assays were performed 
in HBSS supplemented with 20 mM Hepes, pH 7.4. Cells were kept at 4°C 
throughout the separation and were prewarmed to 37°C before the assay.
To obtain immobilized immune complex–coated surfaces, human serum 
albumin (HSA; Sigma-Aldrich) was either bound directly to regular or lumi-
nometric Nunc MaxiSorp F96 (Thermo Fisher Scientific) plates or cova-
lently linked to poly-l-lysine–coated 6-cm tissue culture dishes and then 
treated with anti-HSA IgG (Sigma-Aldrich) as previously described ( Jakus 
et al., 2008). For the analysis of proinflammatory mediator release, 100 µl ali-
quots of 4 × 106/ml neutrophils or 500 µl aliquots of 3 × 106/ml macro-
phages suspended in HBSS supplemented with 20 mM Hepes, pH 7.4, were 
plated on immobilized immune complex surfaces in 96-well ELISA plates or 
24-well tissue culture plates, respectively, stimulated for 6 or 24 h, respectively, 
and the inflammatory mediator concentration of the supernatant was deter-
mined as described below. For the analysis of LTB4 production, 100 µl ali-
quots of 4 × 106/ml neutrophils or 500 µl aliquots of 3 × 106/ml macrophages 
suspended in DMEM (Sigma-Aldrich) were plated on immobilized immune 
complex surfaces in 96-well ELISA plates or 24-well tissue culture plates, re-
spectively, for 1 h and the LTB4 concentration of the cell-free supernatant 
was measured as described below. Superoxide release by neutrophils was fol-
lowed by a cytochrome c reduction test from 100 µl aliquots of 4 × 106/ml 
cells plated on immune complex–coated surfaces in 96-well ELISA plates as 
previously described (Németh et al., 2010). To test ROS production by macro-
phages, 100 µl aliquots of 3 × 106/ml cells were plated on immune complex–
coated surfaces in 96-well luminometric ELISA plates in the presence of 
50 µg/ml lucigenin (Sigma-Aldrich), and the chemiluminescence of the sam-
ples was followed by a luminometer (Mithras LB 940; Berthold).
In vitro migration of neutrophils and monocytes was tested using a 
Transwell (Corning) assay with inserts of 3 µm pore size coated with human 
fibrinogen as previously described (Jakus et al., 2009). 100 ng/ml MIP-2, 
100 ng/ml MCP-1, 100 ng/ml MIP-1 (all from PeproTech) or 50 ng/ml 
LTB4 (Santa Cruz Biotechnology, Inc.) was used as chemoattractants. Trans-
migrated cells were counted using a Neubauer chamber (monocytes) or 
measured by an acid phosphatase assay (neutrophils; Jakus et al., 2009).
To test neutrophil adhesion to ICAM-1, 96-well ELISA plates were coated 
with 10 µg/ml recombinant mouse ICAM-1 (Fc chimera; R&D Systems) 
in 50 mM carbonate buffer, pH 9.6, and blocked with 10% FCS (Invitrogen). 
4 × 106/ml neutrophils were plated on the ICAM-1–coated surface, stimulated 
with 50 ng/ml mouse TNF (PeproTech), and incubated for 1 h. The adhesion of 
the cells was then determined using an acid phosphatase assay (Jakus et al., 2009).
Analysis of inflammatory mediators. The release of inflammatory me-
diators was tested from the cell-free supernatants of synovial infiltrates or of 
in vitro stimulated neutrophils or macrophages. Semiquantitative analysis of 
the level of inflammation-related chemokines and cytokines was performed 
using a mouse cytokine antibody array kit (Panel A from R&D Systems) ac-
cording to the manufacturer’s instructions and quantified using densitometry 
of x-ray films. The levels of IL-1, KC, MCP-1, MIP-1, and MIP-2, as well 
as of the lipid mediator LTB4, were further tested by commercial ELISA kits 
(R&D Systems) according to the manufacturer’s instructions.
Reverse passive Arthus reaction. To trigger the cutaneous reverse passive 
Arthus reaction, WT or Hck/Fgr/Lyn/ mice were anesthetized by 
2.5% tribromoethanol (Sigma-Aldrich) in PBS and injected intradermally 
into the right ear, with 20 µl rabbit polyclonal anti–chicken egg albumin 
(Ova; Sigma-Aldrich) whole serum diluted twofold in PBS. Similarly pre-
pared normal rabbit serum (Sigma-Aldrich) was injected into the left ears as 
controls. This was immediately followed by i.v. injection of 0.4 mg ovalbu-
min (Sigma-Aldrich). 2 h later, the mice were injected i.v. with 80 MBq 
99mTc-labeled human serum albumin (prepared using the Albumon HSA 
99mTc labeling kit from Medi-Radiopharma, and 99mTc-pertechnetate har-
vested from a Sorin/Drygen generator from Izotóp Intézet). After two more 
hours, mice were anesthetized with 10% urethan and the distribution of the 
radioactivity was detected using a NanoSPECT/CT Silver Upgrade SPECT/
CT system (Mediso) along with a reference CT scan. Data were processed 
using the Fusion (Mediso) and VivoQuant (inviCRO) software. The radioac-
tivity of the ears was normalized to that of the entire head area.
In vivo analysis of myeloid cell migration. In case of the K/B×N serum 
transfer model, the ankle or front paw area was flushed with 1 ml PBS supple-
mented with 10 mM EDTA (pH 7.5) and 20 mM HEPES (pH 7.4; Sigma) 
on day 4 to obtain a sample of synovial infiltrate. In case of the autoantibody-
induced skin blistering model, the skin of the buccal area (which was most 
consistently affected by disease development) was isolated on day 7, minced, 
and digested with 28 U/ml Liberase and 10 mg/ml DNase I (both from 
Roche) in Ca2+ and Mg2+-containing Hank’s balanced salt solution (HBSS; 
Invitrogen) supplemented with 20 mM Hepes, pH 7.4, for 1 h at 37°C with 
thorough stirring. The number and distribution of the myeloid cells in the re-
sulting suspension was then determined by flow cytometry. Myeloid cell types 
were identified based on their typical forward and side scatter characteristics, 
as well as by positive staining of neutrophils for Ly6G (clone 1A8; BD), or 
positive staining of monocytes/macrophages for F4/80 (clone A3-1; AbD 
Serotec) or CD11b (clone M1/70; BD) within the Ly6G-negative gate.
A competitive migration assay in mixed bone marrow chimeras ( Jakus 
et al., 2009) was also used to assess in vivo migration of myeloid cells. To this 
end, WT (C57BL/6), Hck/Fgr/Lyn/, CD18/, or FcR/ bone 
marrow cells (all carrying the CD45.2 allele) were mixed at varying ratios 
ranging from 1:4 to 4:1 with bone marrow cells from congenic mice express-
ing CD45.1 on the C57BL/6 genetic background. This mixed cell suspen-
sion was injected intravenously into lethally irradiated CD45.1-expressing 
recipient mice, giving rise to mixed bone marrow chimeras carrying CD45.2- 
expressing WT, CD18/, Hck/Fgr/Lyn/, or FcR/, along with 
CD45.1-expressing WT hematopoietic cells within the same animals. 5–8 wk 
after transplantation, the chimeras were subjected to K/B×N serum transfer 
arthritis and their synovial infiltrates were prepared as described above. The 
percentage of CD45.2-expressing cells within the above defined neutrophil 
and monocyte/macrophage gates from the synovial infiltrate and from pe-
ripheral blood samples were analyzed by flow cytometry as described above, 
with an additional staining for CD45.2 (clone 104; BD).
Relative migration (accumulation) of the CD45.2-positive neutrophils 
or monocytes/macrophages (relative to the CD45.1-expressing WT cells) 
was calculated as follows:
	 	
relative migration  
percentage of CD45.2 cells in synovia
=
l infiltrate
percentage of CD45.2 cells in blood
perc






entage of CD45.1 cells in synovial infiltrate
percentage of CD45.1 cells in blood






	
Isolation and activation of neutrophils, monocytes, and macrophages. 
Mouse neutrophils were isolated from the bone marrow of the femurs and 
tibias of intact mice by hypotonic lysis followed by Percoll (GE Healthcare) 
gradient centrifugation using sterile and endotoxin-free reagents as previ-
ously described (Mócsai et al., 2003). Cells were kept at room temperature in 
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Table S1.  Densitometric analysis of cytokine array data. Densitometric analysis of the cytokine arrays performed as described for 
Figs. 6 A, 7 C, and 8 B (corresponding to sections A, B, and C of this table, respectively). The table shows mean of arbitrary densi-
tometric values from 2 independent experiments for each group. IC, immune complex. Table S1 is provided as an Excel file.
